RELJA Innovations™, a medical device company focused on surgical technologies for foot and ankle surgeons, has appointed David Kelly as Chief Commercial Officer. Kelly will lead the commercialization of RELJA's bunion surgery products, including the recently launched RELJA Clamp™, a radiolucent, single-use clamp designed for the Lapidus Bunion Procedure, MIS Bunion Procedures, Lisfranc Fracture Reductions, and Midfoot and Hindfoot Fusions.
RELJA’s offerings also include the RELJA Lapidus System™, RELJA MIS Chevron Precision Bunion System™, the only chevron-style MIS solution, and the RELJA MTP Plating System.
Kelly brings extensive experience in medical sales management, particularly in the foot and ankle market. He has held senior leadership roles at companies such as OsteoMed, Biomet, TriMed, Trilliant Surgical, and Enovis. He played a key role in the successful exits of Trilliant Surgical and RedPoint Medical.
His appointment reflects RELJA’s commitment to expanding its reach among foot and ankle surgeons in the U.S. and advancing strategic commercial initiatives for its current product portfolio and research pipeline.
